Immage Biotherapeutics Corp Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Immage Biotherapeutics are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Immage Biotherapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, Immage Biotherapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Immage |
Immage Biotherapeutics Relative Risk vs. Return Landscape
If you would invest (100.00) in Immage Biotherapeutics Corp on September 4, 2024 and sell it today you would earn a total of 100.00 from holding Immage Biotherapeutics Corp or generate -100.0% return on investment over 90 days. Immage Biotherapeutics Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Immage, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Immage Biotherapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immage Biotherapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Immage Biotherapeutics Corp, and traders can use it to determine the average amount a Immage Biotherapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IMMG |
Based on monthly moving average Immage Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immage Biotherapeutics by adding Immage Biotherapeutics to a well-diversified portfolio.
Immage Biotherapeutics Fundamentals Growth
Immage Stock prices reflect investors' perceptions of the future prospects and financial health of Immage Biotherapeutics, and Immage Biotherapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immage Stock performance.
| Return On Equity | -11.34 | |||
| Return On Asset | -4.96 | |||
| Current Valuation | 32.93 K | |||
| Shares Outstanding | 151.74 M | |||
| Price To Earning | (0.01) X | |||
| EBITDA | (1.82 M) | |||
| Cash And Equivalents | 53.69 K | |||
| Debt To Equity | 2.52 % | |||
| Cash Flow From Operations | (215.82 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 243.1 K | |||
| Current Asset | 75 K | |||
| Current Liabilities | 58 K | |||
About Immage Biotherapeutics Performance
By analyzing Immage Biotherapeutics' fundamental ratios, stakeholders can gain valuable insights into Immage Biotherapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Immage Biotherapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Immage Biotherapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Immage Biotherapeutics Corp. does not have significant business operations. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited. IMMAGE BIOTHERAPEUTICS is traded on OTC Exchange in the United States.Things to note about Immage Biotherapeutics performance evaluation
Checking the ongoing alerts about Immage Biotherapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immage Biotherapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Immage Biotherapeutics is not yet fully synchronised with the market data | |
| Immage Biotherapeutics has some characteristics of a very speculative penny stock | |
| Immage Biotherapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.81, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Immage Biotherapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (216.48 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Immage Biotherapeutics Corp currently holds about 53.69 K in cash with (215.82 K) of positive cash flow from operations. | |
| Roughly 70.0% of the company shares are held by company insiders |
- Analyzing Immage Biotherapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immage Biotherapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Immage Biotherapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Immage Biotherapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immage Biotherapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Immage Biotherapeutics' stock. These opinions can provide insight into Immage Biotherapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |